Related references
Note: Only part of the references are listed.Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis
Olga Khomich et al.
CELLS (2020)
Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib
Yang Yang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Natascha Roehlen et al.
CELLS (2020)
Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology
Wei Zhou et al.
BMC COMPLEMENTARY MEDICINE AND THERAPIES (2020)
Burden of liver diseases in the world
Sumeet K. Asrani et al.
JOURNAL OF HEPATOLOGY (2019)
Effect of Compound Kushen Injection, a Natural Compound Mixture, and Its Identified Chemical Components on Migration and Invasion of Colon, Brain, and Breast Cancer Cell Lines
Saeed Nourmohammadi et al.
FRONTIERS IN ONCOLOGY (2019)
ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice
Weiguo Fan et al.
GASTROENTEROLOGY (2019)
ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis
Beatrice Foglia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Praziquantel ameliorates CCl4-induced liver fibrosis in mice by inhibiting TGF-β/Smad signalling via up-regulating Smad7 in hepatic stellate cells
Jinfeng Liu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma
Ram C. Shankaraiah et al.
ONCOGENE (2019)
Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response
Bridget P. Keenan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Antifibrotics in liver disease: are we getting closer to clinical use?
Meena B. Bansal et al.
HEPATOLOGY INTERNATIONAL (2019)
HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma
George N. Ioannou et al.
JOURNAL OF HEPATOLOGY (2018)
Targeting TGF-β signaling for the treatment of fibrosis
Andrea Hermina Gyoerfi et al.
MATRIX BIOLOGY (2018)
Matrix metalloproteinase functions in hepatic injury and fibrosis
Martin Roderfeld
MATRIX BIOLOGY (2018)
Liver fibrosis: Direct antifibrotic agents and targeted therapies
Detlef Schuppan et al.
MATRIX BIOLOGY (2018)
Drug Repurposing for Viral Infectious Diseases: How Far Are We?
Beatrice Mercorelli et al.
TRENDS IN MICROBIOLOGY (2018)
Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis
Isabel Fabregat et al.
FRONTIERS IN ONCOLOGY (2018)
Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway
Yanxia Jin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-beta/Smad signaling pathway
Mao Mu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Efficacy and Safety of Compound Kushen Injection on Patients with Advanced Colon Cancer: A Meta-Analysis of Randomized Controlled Trials
Lixiu Yu et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)
Liver inflammation and fibrosis
Yukinori Koyama et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Smad7 enables STAT3 activation and promotes pluripotency independent of TGF-β signaling
Yi Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Regression of Liver Fibrosis
Lara Campana et al.
SEMINARS IN LIVER DISEASE (2017)
Hepatic stellate cells as key target in liver fibrosis
Takaaki Higashi et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
USP26 regulates TGF-β signaling by deubiquitinating and stabilizing SMAD7
Sarah Kit Leng Lui et al.
EMBO REPORTS (2017)
Revisiting Repurposing
Elizabeth R. Sharlow
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2016)
Efficacy of Compound Kushen Injection in Combination with Induction Chemotherapy for Treating Adult Patients Newly Diagnosed with Acute Leukemia
Honglei Tu et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice
Xiao-Feng Lei et al.
JOURNAL OF HEPATOLOGY (2016)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
A multicenter randomized controlled open-label trial to assess the efficacy of compound kushen injection in combination with single-agent chemotherapy in treatment of elderly patients with advanced non-small cell lung cancer: study protocol for a randomized controlled trial
Xue-qian Wang et al.
TRIALS (2016)
Anti-tumor activities of active ingredients in Compound Kushen Injection
Wei Wang et al.
ACTA PHARMACOLOGICA SINICA (2015)
Smad7 regulates compensatory hepatocyte proliferation in damaged mouse liver and positively relates to better clinical outcome in human hepatocellular carcinoma
Teng Feng et al.
CLINICAL SCIENCE (2015)
Hepatic Inflammation and Fibrosis: Functional Links and Key Pathways
Ekihiro Seki et al.
HEPATOLOGY (2015)
Hepatic fibrosis: Concept to treatment
Christian Trautwein et al.
JOURNAL OF HEPATOLOGY (2015)
Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway
X. Zhao et al.
CELL DEATH & DISEASE (2015)
Fufang Kushen injection inhibits sarcoma growth and tumor-induced hyperalgesia via TRPV1 signaling pathways
Zhizheng Zhao et al.
CANCER LETTERS (2014)
Hepatic stellate cells in liver development, regeneration, and cancer
Chunyue Yin et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
Ingmar Mederacke et al.
NATURE COMMUNICATIONS (2013)
Dynamics and feedback loops in the transforming growth factor β signaling pathway
Katja Wegner et al.
BIOPHYSICAL CHEMISTRY (2012)
TGF-β in progression of liver disease
Steven Dooley et al.
CELL AND TISSUE RESEARCH (2012)
Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway
Weiru Xu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Canonical Wnt signaling maintains the quiescent stage of hepatic stellate cells
Claus Kordes et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF-β dependent fashion
M. Mikula et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
An appraisal of the histopathological assessment of liver fibrosis
RA Standish et al.
GUT (2006)
Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats
S Dooley et al.
GASTROENTEROLOGY (2003)
Share Paper
